Microsoft Ventures, which previously led a $9m series A round, has returned to back a $25m series B that will help Aqua Security strengthen its market position.

AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.

The graph database platform has emerged from stealth with $31m in series A funding from investors including Baidu and Ant Financial.

Jet chartering marketplace Victor has raised $20m, half of which was invested by BP Ventures as part of a commercial agreement with Air BP.

Neurological drug developer Rodin Therapeutics has now raised more than $57m in total, its past investors including Johnson and Johnson and Biogen.

Salesforce Ventures and CreditEase Fintech Investment Fund contributed to a $34.6m round that will help the female-focused investment platform add new services.

The LVMH-backed private equity firm has acquired a 27.9% stake in craft beer brewer Innis & Gunn in return for a $20.3m investment.

The surgery robotics developer has added $26m from investors including ABB Technology Ventures to complete its series A round, 14 months after closing the first tranche.

MycoTechnology, the developer of a mushroom-based vegan protein, secured the capital in a round co-led by Bunge that included Kellogg and Continental Grain.

The digital locksmith has now raised more than $100m since 2012, after closing a Comcast Ventures-led round that included fellow returning investors including 7-Eleven.